Does the media prefer STAA or PROF?

In the previous week, STAAR Surgical had 10 more articles in the media than Profound Medical. MarketBeat recorded 14 mentions for STAAR Surgical and 4 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.65 beat STAAR Surgical's score of 0.47 indicating that Profound Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 4 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Which has preferable earnings and valuation, IRMD or PROF?

iRadimed has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iRadimed $83.81M 13.78 $22.48M $1.79 50.43 Profound Medical $16.10M 16.57 -$42.57M -$0.46 N/A

Does the media favor IRMD or PROF?

In the previous week, iRadimed had 3 more articles in the media than Profound Medical. MarketBeat recorded 7 mentions for iRadimed and 4 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.65 beat iRadimed's score of 0.19 indicating that Profound Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRadimed 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer PROF or DRTS?

In the previous week, Alpha Tau Medical had 5 more articles in the media than Profound Medical. MarketBeat recorded 9 mentions for Alpha Tau Medical and 4 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.65 beat Alpha Tau Medical's score of 0.60 indicating that Profound Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Alpha Tau Medical 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, BVS or PROF?

Bioventus has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bioventus $568.09M 2.05 $22.73M $0.77 18.13 Profound Medical $16.10M 16.57 -$42.57M -$0.46 N/A

Does the media favor BVS or PROF?

In the previous week, Bioventus had 13 more articles in the media than Profound Medical. MarketBeat recorded 17 mentions for Bioventus and 4 mentions for Profound Medical. Bioventus' average media sentiment score of 0.65 beat Profound Medical's score of 0.65 indicating that Bioventus is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bioventus 5 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media refer more to PROF or PRCT?

In the previous week, PROCEPT BioRobotics had 49 more articles in the media than Profound Medical. MarketBeat recorded 53 mentions for PROCEPT BioRobotics and 4 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.65 beat PROCEPT BioRobotics' score of 0.02 indicating that Profound Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Profound Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive PROCEPT BioRobotics 5 Very Positive mention(s) 2 Positive mention(s) 41 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Profound Medical (PROF) Competitors

$7.34 -0.07 (-0.94%)

As of 04:00 PM Eastern

Compare

PROF vs. STAA, IRMD, DRTS, BVS, and PRCT

Should you buy Profound Medical stock or one of its competitors? Profound Medical's main competitors and comparable companies include STAAR Surgical (STAA), iRadimed (IRMD), Alpha Tau Medical (DRTS), Bioventus (BVS), and PROCEPT BioRobotics (PRCT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Profound Medical compare to STAAR Surgical?

STAAR Surgical (NASDAQ:STAA) and Profound Medical (NASDAQ:PROF) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

In the previous week, STAAR Surgical had 10 more articles in the media than Profound Medical. MarketBeat recorded 14 mentions for STAAR Surgical and 4 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.65 beat STAAR Surgical's score of 0.47 indicating that Profound Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	4 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Profound Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

STAAR Surgical presently has a consensus target price of $26.94, indicating a potential upside of 7.26%. Profound Medical has a consensus target price of $11.50, indicating a potential upside of 56.68%. Given Profound Medical's stronger consensus rating and higher probable upside, analysts clearly believe Profound Medical is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	3 Sell rating(s)	6 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.15
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Profound Medical has lower revenue, but higher earnings than STAAR Surgical. STAAR Surgical is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	5.22	-$80.45M	-$0.43	N/A
Profound Medical	$16.10M	16.57	-$42.57M	-$0.46	N/A

STAAR Surgical has a net margin of -7.24% compared to Profound Medical's net margin of -66.62%. STAAR Surgical's return on equity of 3.31% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	-7.24%	3.31%	2.55%
Profound Medical	-66.62%	-24.47%	-19.90%

STAAR Surgical has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market. Comparatively, Profound Medical has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market.

96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 47.9% of Profound Medical shares are held by institutional investors. 39.9% of STAAR Surgical shares are held by insiders. Comparatively, 1.5% of Profound Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

STAAR Surgical beats Profound Medical on 10 of the 16 factors compared between the two stocks.

How does Profound Medical compare to iRadimed?

iRadimed (NASDAQ:IRMD) and Profound Medical (NASDAQ:PROF) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends, media sentiment and valuation.

iRadimed has a net margin of 26.70% compared to Profound Medical's net margin of -66.62%. iRadimed's return on equity of 23.45% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRadimed	26.70%	23.45%	20.36%
Profound Medical	-66.62%	-24.47%	-19.90%

iRadimed presently has a consensus price target of $120.00, suggesting a potential upside of 32.93%. Profound Medical has a consensus price target of $11.50, suggesting a potential upside of 56.68%. Given Profound Medical's higher probable upside, analysts plainly believe Profound Medical is more favorable than iRadimed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRadimed	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, iRadimed had 3 more articles in the media than Profound Medical. MarketBeat recorded 7 mentions for iRadimed and 4 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.65 beat iRadimed's score of 0.19 indicating that Profound Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRadimed	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Profound Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

iRadimed has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRadimed	$83.81M	13.78	$22.48M	$1.79	50.43
Profound Medical	$16.10M	16.57	-$42.57M	-$0.46	N/A

92.3% of iRadimed shares are owned by institutional investors. Comparatively, 47.9% of Profound Medical shares are owned by institutional investors. 34.6% of iRadimed shares are owned by company insiders. Comparatively, 1.5% of Profound Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

iRadimed has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market. Comparatively, Profound Medical has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market.

Summary

iRadimed beats Profound Medical on 13 of the 16 factors compared between the two stocks.

How does Profound Medical compare to Alpha Tau Medical?

Profound Medical (NASDAQ:PROF) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

Alpha Tau Medical has a net margin of 0.00% compared to Profound Medical's net margin of -66.62%. Profound Medical's return on equity of -24.47% beat Alpha Tau Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Profound Medical	-66.62%	-24.47%	-19.90%
Alpha Tau Medical	N/A	-73.23%	-52.90%

Profound Medical presently has a consensus target price of $11.50, suggesting a potential upside of 56.68%. Alpha Tau Medical has a consensus target price of $12.60, suggesting a potential downside of 7.35%. Given Profound Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Profound Medical is more favorable than Alpha Tau Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Alpha Tau Medical	1 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.50

47.9% of Profound Medical shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 1.5% of Profound Medical shares are held by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Alpha Tau Medical had 5 more articles in the media than Profound Medical. MarketBeat recorded 9 mentions for Alpha Tau Medical and 4 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.65 beat Alpha Tau Medical's score of 0.60 indicating that Profound Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Profound Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Alpha Tau Medical	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Profound Medical has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$16.10M	16.57	-$42.57M	-$0.46	N/A
Alpha Tau Medical	N/A	N/A	-$42.63M	-$0.67	N/A

Profound Medical has a beta of 0.73, indicating that its stock price is 27% less volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market.

Summary

Profound Medical beats Alpha Tau Medical on 11 of the 16 factors compared between the two stocks.

How does Profound Medical compare to Bioventus?

Bioventus (NASDAQ:BVS) and Profound Medical (NASDAQ:PROF) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

Bioventus presently has a consensus price target of $16.25, suggesting a potential upside of 16.40%. Profound Medical has a consensus price target of $11.50, suggesting a potential upside of 56.68%. Given Profound Medical's higher possible upside, analysts clearly believe Profound Medical is more favorable than Bioventus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bioventus	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.00
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Bioventus has a net margin of 9.36% compared to Profound Medical's net margin of -66.62%. Bioventus' return on equity of 28.08% beat Profound Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioventus	9.36%	28.08%	9.82%
Profound Medical	-66.62%	-24.47%	-19.90%

Bioventus has a beta of 0.63, suggesting that its stock price is 37% less volatile than the broader market. Comparatively, Profound Medical has a beta of 0.73, suggesting that its stock price is 27% less volatile than the broader market.

In the previous week, Bioventus had 13 more articles in the media than Profound Medical. MarketBeat recorded 17 mentions for Bioventus and 4 mentions for Profound Medical. Bioventus' average media sentiment score of 0.65 beat Profound Medical's score of 0.65 indicating that Bioventus is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bioventus	5 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Profound Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

62.9% of Bioventus shares are held by institutional investors. Comparatively, 47.9% of Profound Medical shares are held by institutional investors. 33.5% of Bioventus shares are held by insiders. Comparatively, 1.5% of Profound Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Bioventus has higher revenue and earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioventus	$568.09M	2.05	$22.73M	$0.77	18.13
Profound Medical	$16.10M	16.57	-$42.57M	-$0.46	N/A

Summary

Bioventus beats Profound Medical on 13 of the 16 factors compared between the two stocks.

How does Profound Medical compare to PROCEPT BioRobotics?

Profound Medical (NASDAQ:PROF) and PROCEPT BioRobotics (NASDAQ:PRCT) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

In the previous week, PROCEPT BioRobotics had 49 more articles in the media than Profound Medical. MarketBeat recorded 53 mentions for PROCEPT BioRobotics and 4 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.65 beat PROCEPT BioRobotics' score of 0.02 indicating that Profound Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Profound Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
PROCEPT BioRobotics	5 Very Positive mention(s)	2 Positive mention(s)	41 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

47.9% of Profound Medical shares are owned by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by company insiders. Comparatively, 4.0% of PROCEPT BioRobotics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profound Medical has higher earnings, but lower revenue than PROCEPT BioRobotics. Profound Medical is trading at a lower price-to-earnings ratio than PROCEPT BioRobotics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Profound Medical	$16.10M	16.57	-$42.57M	-$0.46	N/A
PROCEPT BioRobotics	$308.05M	4.01	-$95.57M	-$1.94	N/A

Profound Medical has a beta of 0.73, meaning that its stock price is 27% less volatile than the broader market. Comparatively, PROCEPT BioRobotics has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market.

Profound Medical presently has a consensus target price of $11.50, suggesting a potential upside of 56.68%. PROCEPT BioRobotics has a consensus target price of $28.00, suggesting a potential upside of 28.97%. Given Profound Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Profound Medical is more favorable than PROCEPT BioRobotics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profound Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
PROCEPT BioRobotics	2 Sell rating(s)	10 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.19

PROCEPT BioRobotics has a net margin of -32.53% compared to Profound Medical's net margin of -66.62%. Profound Medical's return on equity of -24.47% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Profound Medical	-66.62%	-24.47%	-19.90%
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%

Summary

Profound Medical and PROCEPT BioRobotics tied by winning 8 of the 16 factors compared between the two stocks.

Get Profound Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PROF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PROF vs. The Competition

Export

Metric	Profound Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$266.74M	$5.79B	$7.06B	$12.95B
Dividend Yield	N/A	1.78%	2.58%	10.20%
P/E Ratio	-15.96	24.71	269.75	24.74
Price / Sales	16.57	67.44	652.34	108.60
Price / Cash	N/A	33.55	28.89	37.44
Price / Book	4.01	6.21	11.27	6.42
Net Income	-$42.57M	$147.87M	$3.45B	$347.12M
7 Day Performance	-10.92%	3.40%	3.56%	2.48%
1 Month Performance	4.26%	1.66%	-0.58%	-1.04%
1 Year Performance	32.49%	6.26%	77.52%	23.22%

Profound Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PROF Profound Medical	2.9419 of 5 stars	$7.34 -0.9%	$11.50 +56.7%	+33.8%	$266.74M	$16.10M	N/A	150	Positive News
STAA STAAR Surgical	2.7462 of 5 stars	$24.12 -0.9%	$26.94 +11.7%	-11.2%	$1.20B	$239.44M	N/A	1,211	Upcoming Earnings
IRMD iRadimed	2.5947 of 5 stars	$93.13 +1.7%	$120.00 +28.9%	+32.3%	$1.19B	$83.81M	52.03	110	Analyst Downgrade High Trading Volume
DRTS Alpha Tau Medical	1.6274 of 5 stars	$13.08 +9.7%	$12.60 -3.7%	+287.6%	$1.18B	N/A	N/A	80	News Coverage Earnings Report
BVS Bioventus	4.318 of 5 stars	$13.42 -0.4%	$14.75 +9.9%	+104.2%	$1.12B	$568.09M	32.73	1,200	Earnings Report

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PROF) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Profound Medical (PROF) Competitors

PROF vs. STAA, IRMD, DRTS, BVS, and PRCT

How does Profound Medical compare to STAAR Surgical?

Summary

How does Profound Medical compare to iRadimed?

Summary

How does Profound Medical compare to Alpha Tau Medical?

Summary

How does Profound Medical compare to Bioventus?

Summary

How does Profound Medical compare to PROCEPT BioRobotics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PROF vs. The Competition

Profound Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Profound Medical (PROF) Competitors

PROF vs. STAA, IRMD, DRTS, BVS, and PRCT

How does Profound Medical compare to STAAR Surgical?

Does the media prefer STAA or PROF?

Do analysts prefer STAA or PROF?

Which has better earnings and valuation, STAA or PROF?

Is STAA or PROF more profitable?

Which has more risk & volatility, STAA or PROF?

Do institutionals and insiders believe in STAA or PROF?

Summary

How does Profound Medical compare to iRadimed?

Is IRMD or PROF more profitable?

Do analysts prefer IRMD or PROF?

Does the media favor IRMD or PROF?

Which has preferable earnings and valuation, IRMD or PROF?

Do insiders and institutionals hold more shares of IRMD or PROF?

Which has more risk and volatility, IRMD or PROF?

Summary

How does Profound Medical compare to Alpha Tau Medical?

Is PROF or DRTS more profitable?

Do analysts rate PROF or DRTS?

Do institutionals & insiders hold more shares of PROF or DRTS?

Does the media prefer PROF or DRTS?

Which has better earnings & valuation, PROF or DRTS?

Which has more risk and volatility, PROF or DRTS?

Summary

How does Profound Medical compare to Bioventus?

Do analysts prefer BVS or PROF?

Is BVS or PROF more profitable?

Which has more volatility & risk, BVS or PROF?

Does the media favor BVS or PROF?

Do institutionals and insiders hold more shares of BVS or PROF?

Which has preferable valuation & earnings, BVS or PROF?

Summary

How does Profound Medical compare to PROCEPT BioRobotics?

Does the media refer more to PROF or PRCT?

Do insiders & institutionals hold more shares of PROF or PRCT?

Which has preferable valuation & earnings, PROF or PRCT?

Which has more risk and volatility, PROF or PRCT?

Do analysts rate PROF or PRCT?

Is PROF or PRCT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PROF vs. The Competition

Profound Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools